期刊论文详细信息
| Current oncology | |
| Response to: Second-line treatment of non-small-cell lung cancer with wild-type EGFR status. What is the best approach? | |
| J. Agulnik1 G. Kasymjanova1 V. Cohen1 K.A. Ma2 | |
| [1] Jewish General Hospital;McGill University | |
| 关键词: Lung Cancer; EGFR mutation; | |
| DOI : 10.3747/co.23.2955 | |
| 学科分类：肿瘤学 | |
| 来源: Multimed, Inc. | |
 PDF
|
|
【 摘 要 】
-
【 授权许可】
Unknown
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO201902023150470ZK.pdf | 83KB |  download |
878987797
028-85220240
